Tapering antipsychotics with N-Acetylcysteine for stable psychosis
Treatments studied
Part of Mental health clinical trials.
This study tests whether adding N-Acetylcysteine (a supplement) can help safely reduce antipsychotic medication in people with stable psychosis. If you are doing well on a steady dose of antipsychotics, you may be able to gradually lower your dose while taking this supplement.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 60 years old
- You have been diagnosed with schizophrenia or a related psychotic disorder and have been stable (no severe symptoms) for at least 3 months
- You have been taking the same dose of antipsychotic medication for at least 3 months
- You have not changed any other psychiatric medications (like antidepressants or benzodiazepines) in the last 3 months
- You have not been hospitalized for a psychiatric crisis in the last 6 months
- You are not taking mood stabilizers, are not pregnant or breastfeeding, and have no history of substance dependence in the last 6 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a probiotic supplement can help reduce metabolic side effects (like weight gain or high blood sugar) caused by antipsychotic medications. It is for people with psychosis who are on stable treatment.
This trial studies whether NAC (a nutrient-like supplement) can reduce symptoms in people who are at high risk for developing psychosis. It may help by testing a safer, non-standard treatment approach for early warning signs.
This trial tests whether N-acetylcysteine (a supplement-like medicine) can help people with alcohol use disorder reduce or stop drinking. You may be randomly assigned to receive N-acetylcysteine or a comparison treatment, and you’ll complete interviews during the study.
This Phase 2 trial tests whether adding an “NMDA-enhancing” treatment plus an antioxidant can improve ongoing schizophrenia symptoms over 12 weeks. It’s meant for people who still have symptoms even though their usual antipsychotic dose has been stable for at least 3 months.
This study looks at whether N-acetylcysteine (NAC), a supplement/medication, can help autism-related symptoms by trying to target brain chemistry. You may be able to join if you previously took part in a related NAC study and can keep your usual medications steady.
This study tests a new treatment that may help with thinking and memory problems in people with schizophrenia. It is for people whose schizophrenia symptoms are stable and who are already on a steady medication.
Hear when a new Psychosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.